SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules.
Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.
Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their R&D goals
Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.
Choose from a variety of resources to get a better understanding of Syngene’s point of view, expertise or approach to drug discovery, development and manufacturing to ensure client success.
Watch this video to hear our expert Purushottam Singnurkar on the key considerations in Formulation Development.
Watch this video to hear our Head of Clinical Development, Chetan Tamhankar, answer three big questions related to Clinical Development, including advantages of engaging with CROs on a partnership model rather than a transactional vendor model.
Watch this video to hear our expert, Subramanium Naik, answer three big questions related to manufacturing, emerging trends and more.
In this video, our Discovery Services Head, Dr. Kenneth Barr, shares his views on the key factors your should consider when outsourcing your toxicology program.
© 2025. Syngene International Limited